Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.
about
Evolution of MHC-based technologies used for detection of antigen-responsive T cellsT-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy.Systematic evaluation of immune regulation and modulationChallenges in vaccine therapy in hematological malignancies and strategies to overcome them.Cancer immunotherapy: weak beats strong.Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia.
P2860
Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Application of the pMHC Array ...... Patients at Disease Diagnosis.
@ast
Application of the pMHC Array ...... Patients at Disease Diagnosis.
@en
type
label
Application of the pMHC Array ...... Patients at Disease Diagnosis.
@ast
Application of the pMHC Array ...... Patients at Disease Diagnosis.
@en
prefLabel
Application of the pMHC Array ...... Patients at Disease Diagnosis.
@ast
Application of the pMHC Array ...... Patients at Disease Diagnosis.
@en
P2093
P2860
P50
P1433
P1476
Application of the pMHC Array ...... Patients at Disease Diagnosis
@en
P2093
Alison H Banham
Amy Publicover
Dagmar Sigurdardottir
Ghazala Khan
Ghulam J Mufti
Karen Pulford
Matthew Arno
Stephanie A Bonney
Suzanne E Brooks
P2860
P304
P356
10.1371/JOURNAL.PONE.0140483
P407
P577
2015-10-22T00:00:00Z